vietnamese crab exporter

InsideDNA (Asylia Diagnostics)

InsideDNA makes drug discovery faster and cheaper with artificial intelligence and genomics. In 2019, InsideDNA pivoted to Asylia Diagnostics; a Generative AI based cancer diagnostics platform based on multi-modal molecular data to revolutionize immunotherapy safety and efficacy. Asylia builds molecular diagnostics for cancer patients and drug developers to optimize treatment and clinical trials.

Europe Disrupt London 2016

Watch The Pitch

Details

Founded Date
2016
Industries
Biotech Pharmaceuticals
Operating Status
Open
Website
insidedna.io

Founders

Anna Kostikova
Founder

News About InsideDNA (Asylia Diagnostics)

Stay up-to-date on startup Battlefield

Sign up to be notified on critical deadlines, updates, and more!